Cargando…
Safety and Allele-Specific Immunogenicity of a Malaria Vaccine in Malian Adults: Results of a Phase I Randomized Trial
OBJECTIVES: The objectives were to evaluate the safety, reactogenicity, and allele-specific immunogenicity of the blood-stage malaria vaccine FMP1/AS02A in adults exposed to seasonal malaria and the impact of natural infection on vaccine-induced antibody levels. DESIGN: We conducted a randomized, do...
Autores principales: | Thera, Mahamadou A, Doumbo, Ogobara K, Coulibaly, Drissa, Diallo, Dapa A, Sagara, Issaka, Dicko, Alassane, Diemert, David J, Heppner, D. Gray, Stewart, V. Ann, Angov, Evelina, Soisson, Lorraine, Leach, Amanda, Tucker, Kathryn, Lyke, Kirsten E, Plowe, Christopher V |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1851722/ https://www.ncbi.nlm.nih.gov/pubmed/17124530 http://dx.doi.org/10.1371/journal.pctr.0010034 |
Ejemplares similares
-
Safety and Immunogenicity of an AMA-1 Malaria Vaccine in Malian Adults: Results of a Phase 1 Randomized Controlled Trial
por: Thera, Mahamadou A., et al.
Publicado: (2008) -
Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine
por: Laurens, Matthew B., et al.
Publicado: (2017) -
Malaria severity: Possible influence of the E670G PCSK9 polymorphism: A preliminary case-control study in Malian children
por: Arama, Charles, et al.
Publicado: (2018) -
Safety and Immunogenicity of an AMA1 Malaria Vaccine in Malian Children: Results of a Phase 1 Randomized Controlled Trial
por: Thera, Mahamadou A., et al.
Publicado: (2010) -
Impact of a Plasmodium falciparum AMA1 Vaccine on Antibody Responses in Adult Malians
por: Dicko, Alassane, et al.
Publicado: (2007)